Alcami Acquires TriPharm Services to Expand Sterile Fill‑Finish Capacity

Alcami Corporation Acquires Pacific Pharmaceutical Services

January 17, 2024

Healthcare Services

Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.

GHO Capital and The Vistria Group Acquire Alcami Corporation

January 3, 2023

Healthcare Services

GHO Capital Partners and The Vistria Group have acquired a 50/50 controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners. Alcami is a US-based contract development and manufacturing organization (CDMO) with capabilities in sterile fill-finish, formulation and analytical lab services, and cGMP biostorage; Ampersand and Alcami management reinvested significant equity as part of the transaction.

Sterling Pharma Solutions Acquires Alcami's Germantown (WI) API Facility

October 1, 2020

Pharmaceuticals

Sterling Pharma Solutions, a portfolio company of GHO Capital Partners, has acquired Alcami’s Germantown, Wisconsin API development and manufacturing facility. The facility expands Sterling’s US footprint and adds cGMP capacity for complex and hazardous API projects, including plant-scale hydrogenation and cryogenic reactions.

Alcami Acquires Masy BioServices

December 15, 2021

Healthcare Services

Alcami Corporation has completed the acquisition of Masy Systems Inc. (Masy BioServices), a cGMP biostorage and pharma support services provider. The deal expands Alcami's biostorage capacity and complementary pharma support capabilities across multiple U.S. locations; financial terms were not disclosed.

PCI Pharma Services Acquires Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services has completed the acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO previously owned by Ajinomoto Co., Inc. The deal expands PCI’s US sterile manufacturing footprint in San Diego—adding prefilled syringe and cartridge aseptic capabilities, lyophilization and high-potent vial filling (including ADC support)—and is part of a multi-year, roughly $1 billion investment strategy to broaden advanced drug delivery and fill‑finish capacity.

Sterling Pharma Solutions Acquires CiVentiChem US Facility in Cary, North Carolina

April 3, 2019

Pharmaceuticals

UK-based CDMO Sterling Pharma Solutions, a portfolio company of GHO Capital, has acquired the CiVentiChem US facility in Cary, North Carolina to establish a local presence for its North American clients and expand its chemistry development and kilo-scale cGMP capabilities. The acquisition supports Sterling’s strategy to build a global chemistry services business and follows GHO Capital’s majority investment in Sterling earlier this year.